海正药业：拟中标全国药品集中采购

Core Viewpoint - The company and its wholly-owned subsidiary, Hanhui Pharmaceutical, participated in the 11th national centralized drug procurement organized by the Joint Procurement Office, with three products expected to win bids in this procurement round [1] Group 1 - The company announced its participation in the national centralized drug procurement bidding process [1] - The Joint Procurement Office published the preliminary results of the procurement on October 28, 2025 [1] - Three products from the company and Hanhui Pharmaceutical are expected to be selected in this procurement [1]